| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/28/2005 | US20050089980 Novel laccase enzyme and the gene encoding the enzyme |
| 04/28/2005 | US20050089979 Process for continuous solvent production |
| 04/28/2005 | US20050089976 Nucleotide sequences coding for the lysRI gene |
| 04/28/2005 | US20050089974 Fermentative production of d-hydroxyphenylglycine and d-phenylglycine |
| 04/28/2005 | US20050089973 Methods and microorganisms for production of panto-compounds |
| 04/28/2005 | US20050089972 Production of porphyrins |
| 04/28/2005 | US20050089971 Preparation of animal feed containing bacterioferrins and vitamin b5; fermenting at least one microorganism of the Enterobacteriaceae family under conditions suitable for the formation of the cysK gene product cysteine synthase A; site-directed mutagenesis |
| 04/28/2005 | US20050089968 Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin |
| 04/28/2005 | US20050089967 Mutant tyrosine repressor gene and utilization thereof |
| 04/28/2005 | US20050089963 Proteases from gram positive organisms |
| 04/28/2005 | US20050089959 Protoxins, cytotoxins; antibodies; cleavage via trypsin; for lysing human cancer cells |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089956 Via biosynthesis of proteins from Pasteurella |
| 04/28/2005 | US20050089954 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 04/28/2005 | US20050089948 Contains mucolytic agent (cysteine, glutathione, N-acetyl-cysteine, N-isobutyrylcysteine) and bactericide (sodium hydroxide, sodium citrate); centrifuging; reduces cross-contamination |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089910 DNA polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides |
| 04/28/2005 | US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/28/2005 | US20050089887 Novel human ion channel proteins |
| 04/28/2005 | US20050089884 Genes coding for ketosynthase, acyl transferase, acyl carrier protein, ketoreductase, dehydratase and enoyl reductase domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, 4-amino-4-deoxychorismate (ADC) synthase or lyase |
| 04/28/2005 | US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes |
| 04/28/2005 | US20050089876 Human E3alpha ubiquitin ligase family |
| 04/28/2005 | US20050089869 GlcNac phosphotransferase of the lysosomal targeting pathway |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089865 Delta 6 desaturases from primulaceae, expressing plants and pufa-containing oils |
| 04/28/2005 | US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders |
| 04/28/2005 | US20050089846 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 04/28/2005 | US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases |
| 04/28/2005 | US20050089530 Selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 04/28/2005 | US20050089529 Immunization of dairy cattle with GapC protein against Streptococcus infection |
| 04/28/2005 | US20050089528 A polypeptide containing a N-terminal domain of a long form bacterial phosphotransacetylase with the proviso that a polypeptide having a full length phosphotransacetylase is excluded. |
| 04/28/2005 | US20050089527 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |
| 04/28/2005 | US20050089526 Monomeric unit of the complex containin HIV-1 gp120 and HIV-1 gp41, (ii) the gp4l has one or more mutations in its N-terminal helix, and (iii) the gp120 and gp41 are bound to each other by a disulfide bond between a cysteine residue introduced into the gp120 and a cysteine residue introduced into gp41 |
| 04/28/2005 | US20050089519 Bispecific anti-cd19x anti-cd16 antibodies and uses thereof |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542631A1 Listeria-based epha2 vaccines |
| 04/28/2005 | CA2541166A1 Site-specific incorporation of redox active amino acids into proteins |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | EP1526182A2 Subtilisin variants |
| 04/27/2005 | EP1526181A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia |
| 04/27/2005 | EP1526179A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia |
| 04/27/2005 | EP1526140A1 Novel potassium-dependent sodium-calcium exchanger |
| 04/27/2005 | EP1525798A2 Carbohydrate oxidase and use thereof in baking |
| 04/27/2005 | EP1525323A2 Pgc-beta, a novel pgc-1 homologue and uses therefor |
| 04/27/2005 | EP1525321A1 Process for the production of l-lysine using coryneform bacteria |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525312A2 Brachyspira hyodysenteriae vaccine |
| 04/27/2005 | EP1525303A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
| 04/27/2005 | EP1524993A2 Neisserial vaccine compositions comprising a combination of antigens |
| 04/27/2005 | EP1524992A2 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 04/27/2005 | EP1524991A1 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| 04/27/2005 | EP1524990A2 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 04/27/2005 | EP1456352B1 Solid culture medium for micro-organisms and eukaryotic cells and method for its production |
| 04/27/2005 | EP1150707B1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 04/27/2005 | EP1016709B1 Lactobacillus helveticus bacterium having high capability of producing tripeptide, fermented milk product, and process for preparing the same |
| 04/27/2005 | EP1005529B1 Methods for lyophilizing competent cells |
| 04/27/2005 | EP0983367B1 Enantioselective epoxide hydrolases and genes encoding these |
| 04/27/2005 | EP0939818B1 Recombinant toxin fragments |
| 04/27/2005 | EP0877801B1 Morphological mutants of filamentous fungi |
| 04/27/2005 | EP0759981B1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner |
| 04/27/2005 | EP0743983B1 Mammalian thymokine genes |
| 04/27/2005 | CN1610754A Enzymes having dehalogenase activity and methods of use thereof |
| 04/27/2005 | CN1610745A Aminoketone asymmetric reductase and nucleic acid thereof |
| 04/27/2005 | CN1610743A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/27/2005 | CN1610740A Eubacterial RNA-polymerase mutants with altered product production |
| 04/27/2005 | CN1610739A Nucleic acid molecules encoding starch degrading enzymes |
| 04/27/2005 | CN1610737A Phenotypic screen of chimeric proteins |
| 04/27/2005 | CN1610697A E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 04/27/2005 | CN1610696A Antibodies that immunospecifically bind to TRAIL receptors |
| 04/27/2005 | CN1609228A Method for preparing insect cell extract for synthesizing cell-free protein, the insect cell extract and method for synthesizing the cell-free protein by using the insect cell extract |
| 04/27/2005 | CN1609212A Heat shock inducing method for raising the temperature of great volume fermented liquid quickly |
| 04/27/2005 | CN1609208A 3-phosphoglycerate dehydrogenase variants whose inhibition by l-serine is reduced, and genes encoding them |
| 04/27/2005 | CN1609202A Molecular breeding method for quickly obtaining great amount of new transgenic plant varieties |
| 04/27/2005 | CN1609191A Bacillus thringiensis strain and gene with high effect on coleoptera pests |
| 04/27/2005 | CN1609190A Process of culturing photosynthetic bacteria with ultrahigh cell density |
| 04/27/2005 | CN1609189A Bacillus subtilis and its application |
| 04/27/2005 | CN1609188A Prussian blue producing strain and prussian blue producing process with the strain |
| 04/27/2005 | CN1609187A Microbial zymogene prepn and feed and alcohol producing process with zymogene prepn |
| 04/27/2005 | CN1609186A Fusarium |
| 04/27/2005 | CN1198940C Fermentation of clavulanic acid at a controlled level of ammonia |
| 04/27/2005 | CN1198938C Characterisation of gene function using double stranded RNA inhibition |
| 04/27/2005 | CN1198936C Alzheimer's disease secretase |
| 04/27/2005 | CN1198935C Method for prodn, of 1,3-propanediol by recombinant organisms |
| 04/27/2005 | CN1198932C Streptococcus pneumoniae antigens |
| 04/27/2005 | CN1198931C MOraxella catarrhalis BASB034 polypeptides and uses thereof |
| 04/27/2005 | CN1198930C Process for preparing doxorubicin |
| 04/27/2005 | CN1198924C Expression cloning in filamentous fungi |
| 04/27/2005 | CN1198919C Method of producing L-serine by fermentation |
| 04/27/2005 | CN1198918C Live attenuated bacteria of species actinobacillus pleuropneumoniae |
| 04/27/2005 | CN1198913C Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in the active site loop region |
| 04/27/2005 | CN1198912C Bleaching compositions comprising multiply-substd, protease variants |
| 04/27/2005 | CN1198844C Process of high purity albumin production |
| 04/27/2005 | CN1198836C Nucleic acids encoding G-protein coupled receptor involved in sensory |
| 04/27/2005 | CN1198647C Antibodies against human CD40 |
| 04/27/2005 | CN1198641C Antistress agents and functional foods |
| 04/27/2005 | CN1198631C Use of bifidobacteria in preparing medicine for preventing diarrhea |
| 04/26/2005 | US6884872 Immunoglobulins for modulating atpase activity and treating thrombosis, tissue rejection and apoptosis disorders |
| 04/26/2005 | US6884870 Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells |
| 04/26/2005 | US6884779 Hybrid screening analyzing |